Cargando…

Clinical implications in the shift of syndecan-1 expression from the cell membrane to the cytoplasm in bladder cancer

BACKGROUND: To determine the diagnostic and prognostic capability of urinary and tumoral syndecan-1 (SDC-1) levels in patients with cancer of the urinary bladder. METHODS: SDC-1 levels were quantitated by enzyme-linked immunosorbent assay (ELISA) in 308 subjects (102 cancer subjects and 206 non-canc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miyake, Makito, Lawton, Adrienne, Dai, Yunfeng, Chang, Myron, Mengual, Lourdes, Alcaraz, Antonio, Goodison, Steve, Rosser, Charles J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3930286/ https://www.ncbi.nlm.nih.gov/pubmed/24524203 http://dx.doi.org/10.1186/1471-2407-14-86

Ejemplares similares

Investigation of CCL18 and A1AT as potential urinary biomarkers for bladder cancer detection
por: Miyake, Makito, et al.
Publicado: (2013)

Validation and clinicopathologic associations of a urine-based bladder cancer biomarker signature
por: Zhang, Ge, et al.
Publicado: (2014)

Simultaneous multi-analyte urinary protein assay for bladder cancer detection
por: Rosser, Charles J, et al.
Publicado: (2014)

Matrix metalloproteinase-10 promotes tumor progression through regulation of angiogenic and apoptotic pathways in cervical tumors
por: Zhang, Ge, et al.
Publicado: (2014)

Chemokine (C-X-C) ligand 1 (CXCL1) protein expression is increased in aggressive bladder cancers
por: Miyake, Makito, et al.
Publicado: (2013)

Erythropoietin is a JAK2 and ERK1/2 effector that can promote renal tumor cell proliferation under hypoxic conditions
por: Miyake, Makito, et al.
Publicado: (2013)

A Multi-Analyte Assay for the Non-Invasive Detection of Bladder Cancer
por: Goodison, Steve, et al.
Publicado: (2012)

CCL18 in a Multiplex Urine-Based Assay for the Detection of Bladder Cancer
por: Urquidi, Virginia, et al.
Publicado: (2012)

IL-8 as a urinary biomarker for the detection of bladder cancer
por: Urquidi, Virginia, et al.
Publicado: (2012)

A multiplex urinary immunoassay for bladder cancer detection: analysis of a Japanese cohort
por: Goodison, Steve, et al.
Publicado: (2016)

Influencing factors on the NMP-22 urine assay: an experimental model
por: Miyake, Makito, et al.
Publicado: (2012)

A multiplex immunoassay for the non-invasive detection of bladder cancer
por: Shimizu, Yoshiko, et al.
Publicado: (2016)

Diagnostic performance of Oncuria™, a urinalysis test for bladder cancer
por: Hirasawa, Yosuke, et al.
Publicado: (2021)

Bladder Cancer Detection and Monitoring: Assessment of Urine- and Blood-Based Marker Tests
por: Goodison, Steve, et al.
Publicado: (2013)

Mysterious Tasks of Tyrosines in Syndecan-1 Cytoplasmic Tail
por: Rousselle, Patricia, et al.
Publicado: (2009)

Intravesical ALT-803 and BCG Treatment Reduces Tumor Burden in a Carcinogen Induced Bladder Cancer Rat Model; a Role for Cytokine Production and NK Cell Expansion
por: Gomes-Giacoia, Evan, et al.
Publicado: (2014)

Meta-analysis of a 10-plex urine-based biomarker assay for the detection of bladder cancer
por: Masuda, Norihiko, et al.
Publicado: (2018)

Prognostic implication of TERT promoter mutation and circulating tumor cells in muscle-invasive bladder cancer
por: Carrasco, Raquel, et al.
Publicado: (2022)

Locally advanced paraganglioma of the urinary bladder: a case report
por: Beilan, Jonathan, et al.
Publicado: (2013)

Monoclonal Antibody against CXCL1 (HL2401) as a Novel Agent in Suppressing IL6 Expression and Tumoral Growth
por: Miyake, Makito, et al.
Publicado: (2019)

Association of SNPs in the PAI1 Gene with Disease Recurrence and Clinical Outcome in Bladder Cancer
por: Murakami, Kaoru, et al.
Publicado: (2023)

A cytoplasmic C-terminal fragment of syndecan-1 is generated by sequential proteolysis and antagonizes syndecan-1 dependent lung tumor cell migration
por: Pasqualon, Tobias, et al.
Publicado: (2015)

Pheochromocytoma of the urinary bladder: a systematic review of the contemporary literature
por: Beilan, Jonathan A, et al.
Publicado: (2013)

Molecular cloning of syndecan, an integral membrane proteoglycan
Publicado: (1989)

Active surveillance for nonmuscle invasive bladder cancer
por: Miyake, Makito, et al.
Publicado: (2016)

Pretreatment assessment and perioperative nutritional interventions for patients with bladder cancer undergoing radical cystectomy
por: Miyake, Makito, et al.
Publicado: (2018)

The Extracellular and Cytoplasmic Domains of Syndecan Cooperate Postsynaptically to Promote Synapse Growth at the Drosophila Neuromuscular Junction
por: Nguyen, Margaret U., et al.
Publicado: (2016)

Syndecan Transmembrane Domain Specifically Regulates Downstream Signaling Events of the Transmembrane Receptor Cytoplasmic Domain
por: Hwang, Jisun, et al.
Publicado: (2021)

A microRNA biomarker panel for the non-invasive detection of bladder cancer
por: Urquidi, Virginia, et al.
Publicado: (2016)

Differential gene expression profile between progressive and de novo muscle invasive bladder cancer and its prognostic implication
por: Carrasco, Raquel, et al.
Publicado: (2021)

Plasma membrane proteoglycans syndecan-2 and syndecan-4 engage with EGFR and RON kinase to sustain carcinoma cell cycle progression
por: Beauvais, DeannaLee M., et al.
Publicado: (2022)

Syndecan-1 in Cancer: Implications for Cell Signaling, Differentiation, and Prognostication
por: Szatmári, Tünde, et al.
Publicado: (2015)

Validation of Urine-based Gene Classifiers for Detecting Bladder Cancer in a Chinese Study
por: Han, Chengtao, et al.
Publicado: (2018)

Syndecan-3 and syndecan-4 are enriched in Schwann cell perinodal processes
por: Goutebroze, Laurence, et al.
Publicado: (2003)

Soluble Syndecan-1 Levels Are Associated with Survival in Platinum-Treated Bladder Cancer Patients
por: Olah, Csilla, et al.
Publicado: (2020)

Detection of antibodies directed at M. hyorhinis p37 in the serum of men with newly diagnosed prostate cancer
por: Urbanek, Cydney, et al.
Publicado: (2011)

Urinary cell microRNA-based prognostic classifier for non-muscle invasive bladder cancer
por: Ingelmo-Torres, Mercedes, et al.
Publicado: (2017)

Radiosensitization in prostate cancer: mechanisms and targets
por: Palacios, Diego A, et al.
Publicado: (2013)

Application of a multiplex urinalysis test for the prediction of intravesical BCG treatment response: A pilot study
por: Murakami, Kaoru, et al.
Publicado: (2022)

A Diagnostic Gene Expression Signature for Bladder Cancer Can Stratify Cases into Prescribed Molecular Subtypes and Predict Outcome
por: Chen, Runpu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_civsebakc7pgeie0eei3h6j4hs